Skip to content Skip to left sidebar Skip to footer

COVID-19 Vaccine

Pediatric Pfizer (5-11 yrs) COVID Bivalent Booster Pre-Ordering Opening Soon

Pediatric Pfizer (5-11 yrs) COVID Bivalent Booster Pre-Ordering Opening Soon

Currently, anyone aged 12 years or older who has completed at least a primary series is eligible for a bivalent booster, regardless of number or type of prior booster doses received, so long as at least two months have passed since their last COVID-19 vaccine dose. In addition, monovalent mRNA COVID-19 vaccines are no longer authorized as booster doses for individuals 12 years of age and older. If authorized by FDA, CDC anticipates a recommendation for bivalent COVID-19 vaccine as a booster for pediatric age groups in early to mid-October. Bivalent products expected to be under consideration include the bivalent Pfizer-BioNTech vaccine for children aged 5-11 years and bivalent Moderna vaccine in children aged 6-17 years, for those individuals who have already received their primary vaccine series.Here’s what we know:
Pfizer-BioNTech bivalent COVID-19 vaccine for children aged 5-11 years and older is expected to have the following characteristics:
  • Packaged in 10-dose vials in cartons of 10 vials each (100 doses total)
  • Requires diluent (note: awardees will not be able to opt out of receiving ancillary kits)
  • Minimum order quantity of 100 doses in Philavax
  • Vial with an orange cap similar to the existing Pfizer-BioNTech product for this age group, but with a label that identifies it as a bivalent booster
Moderna bivalent COVID-19 vaccine is expected to have the following characteristics:
  • Packaged in 5-dose vials in cartons of 10 vials each (50 doses total), with a minimum order quantity of 100 doses in Philavax
  • The same vial (dark blue cap, gray border) and presentation for Moderna is expected to be used for all authorized age groups (people aged 6 years and older), but volume and dosage expected to differ by age:
    • Adolescents aged 12-17 years: same volume and dosage as for adults aged 18 years and older
    • Children aged 6-11 years: half the volume and dosage as for adults aged 18 years and older (drawn from the same vial), i.e., one vial yields double the number of doses when used for 6–11-year-olds as when used for people aged 12 years and older
Ordering/Administration Information
  • Administration of bivalent boosters for this age range cannot begin until EUAs are issued/updated AND ACIP meets to make formal vaccine recommendations
  • There will be no pre-order period for Moderna bivalent vaccine for children aged 6-11 since this product will already be in the field
  • Pre-ordering for Pfizer 5-11 bivalent boosters is expected to open up on Monday 9/26 and close on Tuesday 9/27 at 5pm
    • This schedule is subject to change depending on CDC guidance
    • Pfizer pre-orders are expected to arrive the week of 10/10. No Deliveries Will be Made on Indigenous People’s Day!
    • NDC – 59267-0565-2

Immunization Techniques Training

Immunization Techniques Training

Wednesday, October 12, 2022, from 8:30 am – 12:00 pm, 1:00 pm – 4:30 pm

**Please arrive 15 minutes early. Late arrivals will not be able to attend.**
The Immunization Program is hosting a FREE Immunization Techniques training this Fall. Class participants are limited and will be taken on a first-come, first-served basis. A maximum of 20 participants will be accepted per session. Participants can only attend one training per year.This half-day, interactive, education session will focus on the basics of vaccine-preventable diseases, vaccines, immunization administration techniques, and pediatric immunization schedules. We encourage attendance by Nurses and Medical Assistants who administer vaccines or who will be administering vaccines in the future. This course is beneficial to new practitioners as well as seasoned practitioners who need a refresher course or would like an update on best practices for administering vaccines.We hope to see you there!
If you have any questions, don’t hesitate to reach out to dphproviderhelp@phila.gov.

Moderna Bivalent Booster Ordering Resumed

Moderna Bivalent Booster Ordering Resumed

Moderna Bivalent Booster ordering has been turned back on in Philavax and Monday.com. Please note: allocations are still limited at this time so providers may not receive what is requested based on dose availability.

Please make sure you are selecting the correct NDC when ordering bivalent boosters (see table below). Selecting the monovalent product code and then selecting booster in the Dose Number column will not allow you to order bivalent doses. You will need to select the correct NDC. All previously submitted orders of bivalent vaccines during the ordering pause will need to be resubmitted for processing.

Moderna Bivalent Ordering Pause

Moderna Bivalent Ordering Pause

Due to limited initial allocations of bivalent vaccines, we are currently unable to approve new Moderna bivalent booster orders. Ordering for Moderna boosters has been turned off in Philavax and made unavailable in Monday.com. The city does expect to receive an allocation increase and we will reopen ordering in Philavax and Monday.com at that time.

Please keep in mind that Moderna is experiencing some delivery delays for previously placed orders as well. We appreciate your patience at this time and apologize for any inconveniences as a result of this delay.

COVID-19 Walk-in Survey

COVID-19 Walk-in Survey

PDPH is interested in learning more about Philadelphia providers’ walk-in capacity. Please complete this brief, four-question survey to assess your site’s ability to accept walk-ins now that bivalent boosters are available. Responses will be collected until 9/14.

COVID Vaccine Expiration Dates

COVID Vaccine Expiration Dates

With expiration dates for some Pfizer lots approaching, we would like to remind providers to be mindful about documenting Beyond Use Dates (BUD) and manufacture expiration dates. Any time you move vaccine from the ultra-low freezer/dry ice shipper to a standard freezer or fridge or from a freezer to a fridge, you should place a BUD label on the vaccine box to keep track of vaccine viability. Both PDPH and the CDC have BUD labels available for printing on label sheets. Check out this link for PDPH BUDs (more label options to come soon): Forms and Resources – Philadelphia Immunization ProgramImportant Tip: A Beyond Use Date can never extend pass a manufacture expiration date. You have to use vaccines by whichever date comes first.Pfizer
Moderna
Novavax
  • Novavax lot/expiration date lookup tool
  • Does not have BUDs labels presently as vaccine arrives refrigerated – use manufacture expiration date and use expiration tool to check date prior to each use
Janssen
  • Janssen lot/expiration date lookup tool
    • Many lots approaching expiration
  • Does not have BUDs labels presently as vaccine arrives refrigerated – use manufacture expiration date and use expiration tool to check date prior to each use

Monovalent (Original Formulation) mRNA Vaccines No Longer Authorized for Boosters

Monovalent (Original Formulation) mRNA Vaccines No Longer Authorized for Boosters

An important note: Monovalent mRNA COVID-19 vaccines are NO LONGER authorized for use as boosters in people ages 12 years and older.
  • From the FDA press release: With today’s authorization, the monovalent mRNA COVID-19 vaccines are not authorized as booster doses for individuals 12 years of age and older.
Appointments for monovalent Pfizer-BioNTech or Moderna boosters in people 12 years of age and older must be rescheduled for when locations have the bivalent COVID-19 vaccines available.Please check out the FDA landing pages below for updated EUAs for existing products and new EUAs for the bivalent products.
Remember: Bivalent vaccines cannot be administered until ACIP convenes and makes formal recommendations (expected tomorrow or Thursday).

Bivalent Pfizer and Moderna Booster Vaccines Now Available for Ordering

Bivalent Pfizer and Moderna Booster Vaccines Now Available for Ordering

Providers can now sign into Philavax to place your orders. Orders are due by Wednesday at 5pm.Please note: bivalent vaccine orders will ship sometime after Labor Day. No vaccines will be delivered on Labor Day. Monday.com ordering, partial orders, will not be available until the week after Labor Day. Please do not place Monday.com orders for bivalent vaccines at this time.

Bivalent Pfizer and Moderna Boosters Are Coming

Bivalent Pfizer and Moderna Boosters Are Coming

On June 30, 2022, the U.S. Food and Drug Administration (FDA) advised manufacturers seeking to update their COVID-19 vaccines to add an Omicron BA.4/5 spike protein component to the current vaccine composition to create a bivalent booster vaccine. Pending potential FDA Emergency Use Authorizations (EUAs) for new bivalent COVID-19 boosters developed by Pfizer-BioNTech and Moderna in or around September 2022, CDC’s Advisory Committee on Immunization Practices (ACIP) will convene to discuss potential recommendations. Administration of any new bivalent COVID-19 boosters can begin only after CDC’s official recommendations.What We Know So Far:
  • Pre-ordering for both Pfizer and Moderna bivalent boosters will begin on Monday, August 22, 2022, and close Wednesday, August 24, 2022, at 5pm.
    • Sites should plan to manage necessary freezer/refrigerator space as well as inventory/ordering to avoid waste when developing their overall fall vaccine plans.
  • These bivalent formulas can only be used for boosters for individuals who have completed their primary series.
  • Bivalent boosters will include a BA.4/5 valence specifically.
  • The original Pfizer and Moderna vaccine formulas should only be used for primary series vaccinations once the bivalent products arrive.
    • As the cap colors/borders will be the same for bivalent boosters and the original formulas, sites will need to be mindful of packaging/labeling to differentiate the two products.
  • Delivery will begin after Labor Day – date TBD.
  • ACIP will meet to make official recommendations about vaccine intervals and dosing schedules.
  • EUAs for these two bivalent products are not yet available.
  • It is expected that at least one bivalent vaccine for children ages 11 years and younger may be authorized within a short time following the authorization(s) of bivalent vaccines for people ages 12 years and older.
Pfizer Bivalent Booster
Age: 12+ – pendingShips: Ultra-cold on dry iceStorage: Ultra-cold – until manufacture expiration date             Fridge – 10 weeksDoses per vial: 6Cap color: GreyMinimum Order Quantity: 300 doses (5 boxes)Moderna Bivalent BoosterAge: 18+ – pendingShips: FrozenStorage: Frozen – until manufacture expiration date             Fridge – 30 daysDoses per vial: 5Cap color: BlueMinimum Order Quantity: 100 doses (2 boxes)

Full CDC Vaccination Record Cards

Full CDC Vaccination Record Cards

Vaccination record cards for many recipients of COVID-19 vaccines are now full, especially for those who are over 50 and/or immunocompromised. If a vaccination card is full, the CDC recommends that a second card be completed, and the two cards stapled together. Encourage the patient to photograph both cards in case the two become separated, if possible. Both cards should be presented when vaccination history is required for travel, employment, or any other purpose requiring official, universally recognized documentation. Patients should bring both cards to future vaccination appointments for verification of vaccination history.


When a Vaccination Record Card is Full:
  • Complete a new card for the patient
  • Staple both cards together
  • Encourage the patient to photograph both cards in case they become separated
  • Bring both cards to future vaccination appointments
Providers are supplied with CDC vaccination cards as part of the ancillary kits in a 1:1 dose/card ratio. Many providers are reporting an abundant supply of CDC vaccination cards. Please utilize your current supply of vaccination cards to support distribution of a second card to those that need them. If your site has any concerns about your vaccination card supply, please reach out to PDPH.